Jagsonpal Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 605.26 million compared to INR 583.93 million a year ago. Revenue was INR 616.47 million compared to INR 586.78 million a year ago. Net income was INR 104.12 million compared to INR 65.64 million a year ago. Basic earnings per share from continuing operations was INR 3.97 compared to INR 2.51 a year ago. Diluted earnings per share from continuing operations was INR 3.97 compared to INR 2.51 a year ago.
For the six months, sales was INR 1,211.23 million compared to INR 1,124.48 million a year ago. Revenue was INR 1,225.57 million compared to INR 1,135.55 million a year ago. Net income was INR 133.34 million compared to INR 131.44 million a year ago. Basic earnings per share from continuing operations was INR 5.09 compared to INR 5.02 a year ago. Diluted earnings per share from continuing operations was INR 5.09 compared to INR 5.02 a year ago.